Playing some beaten up biotechs. You know one of them--CUBT.
Getting the National Institutes of Health to underwrite clinical trials for metformin eyedrops for the treat of macular degeneration is very significant--yet the market yawned because, imo, shareholders have tired of waiting for more news that just this.
And I think that there s more news coming. The quiet period is overdue for being over. Watching this one for more news and the shift from selling by old investors to buying (from new investors). JMO
SBFM was a nice scalping trade this past week. In and out.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.